- Sector: Healthcare
- Industry: Biotechnology
- Full Time Employees: 57
- Founded in 2014
- HQ inSan Diego, California
- http://www.kuraoncology.com
Tuesday, April 28, 2020
-=Kura Oncology (KURA) :
Rises to its highest levels since December on above 9x average volume, posting gains alongside its peer in the cancer treatments development space, Syndax Pharmaceuticals (SNDX); co's pipeline includes a menin-MLL inhibitor, KO-539.
Labels:
5-year performance,
KURA,
SNDX
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment